Hertl M - Search Results

1

Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study.

Cosgarea R, Pollmann R, Sharif J, Schmidt T, Stein R, Bodea A, Auschill T, Sculean A, Eming R, Greene B, Hertl M, Arweiler N. Cosgarea R, et al. Among authors: hertl m. Sci Rep. 2020 Feb 3;10(1):1667. doi: 10.1038/s41598-020-58548-9. Sci Rep. 2020. PMID: 32015380 Free PMC article.

2

Autoimmune bullous disorders.

Eming R, Hertl M; Autoimmune Diagnostics Working Group. Eming R, et al. Among authors: hertl m. Clin Chem Lab Med. 2006;44(2):144-9. doi: 10.1515/CCLM.2006.027. Clin Chem Lab Med. 2006. PMID: 16475898 Free article. Review.

3

Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption.

Eming R, Rech J, Barth S, Kalden JR, Schuler G, Harrer T, Hertl M. Eming R, et al. Among authors: hertl m. Dermatology. 2006;212(2):177-87. doi: 10.1159/000090659. Dermatology. 2006. PMID: 16484825

4

T cell control in autoimmune bullous skin disorders.

Hertl M, Eming R, Veldman C. Hertl M, et al. J Clin Invest. 2006 May;116(5):1159-66. doi: 10.1172/JCI28547. J Clin Invest. 2006. PMID: 16670756 Free PMC article. Review.

5

Immunoadsorption in pemphigus.

Eming R, Hertl M. Eming R, et al. Among authors: hertl m. Autoimmunity. 2006 Nov;39(7):609-16. doi: 10.1080/08916930600972040. Autoimmunity. 2006. PMID: 17101505 Review.

6

Detection of low avidity desmoglein 3-reactive T cells in pemphigus vulgaris using HLA-DR beta 1*0402 tetramers.

Veldman C, Eming R, Wolff-Franke S, Sonderstrup G, Kwok WW, Hertl M. Veldman C, et al. Among authors: hertl m. Clin Immunol. 2007 Mar;122(3):330-7. doi: 10.1016/j.clim.2006.09.014. Epub 2006 Nov 17. Clin Immunol. 2007. PMID: 17113829

7

Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies).

Niedermeier A, Eming R, Pfütze M, Neumann CR, Happel C, Reich K, Hertl M. Niedermeier A, et al. Among authors: hertl m. Arch Dermatol. 2007 Feb;143(2):192-8. doi: 10.1001/archderm.143.2.192. Arch Dermatol. 2007. PMID: 17309999

8

Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus.

Pfütze M, Niedermeier A, Hertl M, Eming R. Pfütze M, et al. Among authors: hertl m. Eur J Dermatol. 2007 Jan-Feb;17(1):4-11. doi: 10.1684/ejd.2007.0090. Epub 2007 Feb 27. Eur J Dermatol. 2007. PMID: 17324820 Review.

9

Rituximab (anti-CD20 monoclonal antibody)--ultimate or first choice in pemphigus?

Hertl M, Eming R, Borradori L. Hertl M, et al. Dermatology. 2007;214(4):275-7. doi: 10.1159/000100876. Dermatology. 2007. PMID: 17460396 No abstract available.

10

Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases.

Hertl M, Zillikens D, Borradori L, Bruckner-Tuderman L, Burckhard H, Eming R, Engert A, Goebeler M, Hofmann S, Hunzelmann N, Karlhofer F, Kautz O, Lippert U, Niedermeier A, Nitschke M, Pfütze M, Reiser M, Rose C, Schmidt E, Shimanovich I, Sticherling M, Wolff-Franke S. Hertl M, et al. J Dtsch Dermatol Ges. 2008 May;6(5):366-73. doi: 10.1111/j.1610-0387.2007.06602.x. Epub 2008 Jan 14. J Dtsch Dermatol Ges. 2008. PMID: 18201220 English, German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

502 results

Search Page